VICTORIA, BC, Sept. 4, 2024 /PRNewswire/ - Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (TSX:EPRX) (NASDAQ:EPRX), a clinical-stage biotechnology company leveraging its proprietary DiffuSphere™ technology to optimize drug delivery for applications with significant unmet need, today announced that the Company will be presenting at the upcoming H.C. Wainwright 26th Annual Global Investment Conference being held in New York, NY from September 9-11, 2024.
Presentation Details:
The Company's presentation is at 8:00 a.m. ET on Monday, September 9, 2024. Eupraxia invite